CARA Cara Therapeutics Inc. Gross Profitability Margin

Corporate emblem and logo of Cara Therapeutics Inc. (CARA)

Cara Therapeutics, Inc. (CARA) leverages unique drug mechanisms of action to compete for physician attention. The neuromedicine sector serves as a defensive asset, as the demand for innovation remains independent of macroeconomic conditions. The annual gross margin demonstrates market momentum, where the value of 0.00 reflects this status. The business relies on targeted kidney therapy, creating deep B2B clinic loyalty through injection protocols.

Return on Gross Profit: Cara Therapeutics, Inc. (CARA) for 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for caratherapeutics.com (CARA)

- market value and analyst target forecast:
- cash position and cash flow details:
Fundamental valuation:CARA, Cara Therapeutics Inc.
Flagship merchandise of Cara Therapeutics, Inc.

Identifying fundamentally resilient assets requires analyzing a business's ability to generate profit over direct costs. Gross margin measures the portion of revenue remaining after deducting the cost of goods sold, reflecting a company's operational efficiency and pricing power. For Cara Therapeutics, Inc. (CARA), this metric is critical due to its reliance on royalties and clinical trial expenses; therefore, the history of gross profit profitability serves as an indicator of financial viability.

Main competitors

Return on Gross Profit Biogen Corp|Return on Gross Profit NBIX|Regencell Corp (RGC) - Return on Sales by Gross Profit|Gross Margin AXSM|Return on Gross Profit ACADIA Pharmaceuticals ACAD|Gross Margin XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Gross Profitability Margin|SUPN - Gross Profitability|Catalyst Pharmaceuticals Inc (CPRX) - Return on Gross Profit|DNLI (Denali Corp) - Return on Gross Profit|Gross Profit Margin harmonybiosciences.com (HRMY)|Return on Gross Profit BHVN|Gross Margin Amylyx|Gross Margin TRVI|PRAX (Praxis Corp) - Gross Profit Rate|Gross Margin AVXL (anavex.com)|CBLL: Gross Return on Sales|PRTA - Gross Profitability|ALEC - Gross Margin|Annexon Inc. (ANNX) - Gross Profitability|Return on Gross Profit Omeros Corp|Return on Gross Profit NGNE|ACIU: Gross Profit Rate|Return on Gross Profit VYGR (Voyager Corp)|Return on Gross Profit Neumora NMRA|Gross Profitability Scilex Holding Company, Inc. SCLX|Gross Sales Margin Tevogen Bio Inc.|ACOG - Gross Profitability|Gross Sales Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Return on Gross Profit|Cassava Sciences Inc (SAVA) - Gross Margin|Return on Gross Profit ASRT|Gross Margin coyatherapeutics.com|Gross Margin VTGN|Ovid Therapeutics - Gross Return on Sales|Gross Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Return on Gross Profit|ATHE - Gross Profitability|Return on Sales by Gross Profit clene.com CLNN|PEPG: Gross Margin|Gross Return on Sales JUNS|RLMD (Relmada Corp) - Gross Margin|Annovis Bio Inc (ANVS) - Return on Sales by Gross Profit|Gross Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Gross Profit Rate|Gross Profitability Klotho Neurosciences KLTO|NRSN: Gross Return on Sales|RVPH: Return on Gross Profit|MTVA: Gross Profitability|NRXS (NeurAxis Inc) - Return on Gross Profit|Return on Gross Profit Helius Medical Technologies, Inc.|Gross Profitability Passage Bio Inc.|Gross Profit Margin bionomics.com.au NEUP|Gross Margin NERV|Gross Margin Athira Pharma Inc (ATHA)|Gross Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Gross Return on Sales|CYCN - Gross Profitability|Gross Profit Margin Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Return on Gross Profit|Gross Sales Margin Cortigent, Inc. CRGT|Gross Profitability Avenue Therapeutics, Inc.|Return on Gross Profit BrainStorm Cell Therapeutics Inc. (BCLI)|Gross Profitability Chromocell Therapeutics (CHRO)|Gross Profit Ratio ELYM|Gross Profitability Intra-Cellular ITCI|LBPH: Gross Return on Sales|MRNS - Gross Profitability|NKGen Biotech, Inc. (NKGN) - Return on Gross Profit|neurobopharma.com (NRBO) - Gross Profitability|SAGE: Gross Profit Ratio|Gross Profitability Synaptogenix, Inc.|Gross Profitability TRVN|Gross Margin VIGL|Gross Margin anewmeds.com (WENA)|Gross Margin CERE (cerevel.com)